Maurizia Rossan Brunetto
Maurizia Rossan Brunetto
Professore Straordinario Medicina Interna, Dipt Medicina Clinica e Sperimentale, Università di Pisa
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
Statements from the Taormina expert meeting on occult hepatitis B virus infection
G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ...
Journal of hepatology 49 (4), 652-657, 2008
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases
B Coco, F Oliveri, AM Maina, P Ciccorossi, R Sacco, P Colombatto, ...
Journal of viral hepatitis 14 (5), 360-369, 2007
EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
TE Jury
Journal of Hepatology 39, 3-25, 2003
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B
MR Brunetto, F Moriconi, F Bonino, GKK Lau, P Farci, C Yurdaydin, ...
Hepatology 49 (4), 1141-1150, 2009
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein
S Crotta, A Stilla, A Wack, A D'Andrea, S Nuti, U D'Oro, M Mosca, ...
The Journal of experimental medicine 195 (1), 35-42, 2002
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers
MR Brunetto, F Oliveri, P Colombatto, F Moriconi, P Ciccorossi, B Coco, ...
Gastroenterology 139 (2), 483-490, 2010
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study
MR Brunetto, F Oliveri, B Coco, G Leandro, P Colombatto, JM Gorin, ...
Journal of hepatology 36 (2), 263-270, 2002
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage
C Dunn, M Brunetto, G Reynolds, T Christophides, PT Kennedy, ...
The Journal of experimental medicine 204 (3), 667-680, 2007
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.
MR Brunetto, MM Giarin, F Oliveri, E Chiaberge, M Baldi, A Alfarano, ...
Proceedings of the National Academy of Sciences 88 (10), 4186-4190, 1991
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658-660, 2010
T-lymphocyte response to hepatitis C virus in different clinical courses of infection
P Botarelli, MR Brunetto, MA Minutello, P Calvo, D Unutmaz, AJ Weiner, ...
Gastroenterology 104 (2), 580-587, 1993
Hepatitis B surface antigen quantification: why and how to use it in 2011–a core group report
HLY Chan, A Thompson, M Martinot-Peignoux, T Piratvisuth, M Cornberg, ...
Journal of hepatology 55 (5), 1121-1131, 2011
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind …
M Buti, E Gane, WK Seto, HLY Chan, WL Chuang, T Stepanova, AJ Hui, ...
The lancet Gastroenterology & hepatology 1 (3), 196-206, 2016
IL-10–producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection
A Das, G Ellis, C Pallant, AR Lopes, P Khanna, D Peppa, A Chen, P Blair, ...
The Journal of Immunology 189 (8), 3925-3935, 2012
Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis
MR Brunetto
Ital. J. Gastroenterol. 21, 151-154, 1989
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study
GB Gaeta, T Stroffolini, M Chiaramonte, T Ascione, G Stornaiuolo, ...
Hepatology 32 (4), 824-827, 2000
The role of quantitative hepatitis B surface antigen revisited
M Cornberg, VWS Wong, S Locarnini, M Brunetto, HLA Janssen, ...
Journal of hepatology 66 (2), 398-411, 2017
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen
MR Brunetto, F Oliveri, G Rocca, D Criscuolo, E Chiaberge, M Capalbo, ...
Hepatology 10 (2), 198-202, 1989
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
F Bonino, P Marcellin, GKK Lau, S Hadziyannis, R Jin, T Piratvisuth, ...
Gut 56 (5), 699-705, 2007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20